Neurotrophin nerve growth factor (NGF) has been suggested to be involved in age-related neurodegenerative diseases, but no transgenic model is currently available to study this concept. We have obtained In this paper, we analyze the phenotype of aged anti-NGF transgenic mice and demonstrate that these mice acquire an age-dependent neurodegenerative pathology including amyloid plaques, insoluble and hyperphosphorylated , and neurofibrillary tangles in cortical and hippocampal neurons. Aged anti-NGF mice also display extensive neuronal loss throughout the cortex, cholinergic deficit in the basal forebrain, and behavioral deficits. The overall picture is strikingly reminiscent of human Alzheimer's disease. Aged anti-NGF mice represent, to our knowledge, the most comprehensive animal model for this severe neurodegenerative disease. Also, these results demonstrate that, in mice, a deficit in the signaling and͞or transport of NGF leads to neurodegeneration.
During adulthood, the neurotrophin Nerve Growth Factor (NGF) sensitizes
nociceptors, thereby increasing the response to noxious stimuli. The
relationship between NGF and pain is supported by genetic evidence: mutations in
the NGF TrkA receptor in patients affected by an hereditary rare disease
(Hereditary Sensory and Autonomic Neuropathy type IV, HSAN IV) determine a
congenital form of severe pain insensitivity, with mental retardation, while a
mutation in NGFB gene, leading to the aminoacid substitution
R100W in mature NGF, determines a similar loss of pain
perception, without overt cognitive neurological defects (HSAN V). The R100W
mutation provokes a reduced processing of proNGF to mature NGF in cultured cells
and a higher percentage of neurotrophin secreted is in the proNGF form.
Moreover, using Surface Plasmon Resonance we showed that the R100W mutation does
not affect NGF binding to TrkA, while it abolishes NGF binding to p75NTR
receptors. However, it remains to be clarified whether the major impact of the
mutation is on the biological function of proNGF or of mature NGF and to what
extent the effects of the R100W mutation on the HSAN V clinical phenotype are
developmental, or whether they reflect an impaired effectiveness of NGF to
regulate and mediate nociceptive transmission in adult sensory neurons. Here we
show that the R100 mutation selectively alters some of the signaling pathways
activated downstream of TrkA NGF receptors. NGFR100 mutants maintain identical
neurotrophic and neuroprotective properties in a variety of cell assays, while
displaying a significantly reduced pain-inducing activity in
vivo (n = 8–10 mice/group). We also show
that proNGF has a significantly reduced nociceptive activity, with respect to
NGF. Both sets of results jointly contribute to elucidating the mechanisms
underlying the clinical HSAN V manifestations, and to clarifying which receptors
and intracellular signaling cascades participate in the pain sensitizing action
of NGF.
The establishment of synaptic connections and their refinement during development require neural activity. Increasing evidence suggests that spontaneous bursts of neural activity within an immature network are mediated by gamma-aminobutyric acid via a paradoxical excitatory action. Our data show that in the developing hippocampus such synchronous burst activity is generated in the hilar region by transiently coupled cells. These cells have been identified as neuronal elements because they fire action potentials and they are not positive for the glial fibrillary acidic protein staining. Oscillations in hilar cells are "paced" by a hyperpolarization-activated current, with properties of Ih. Coactivated interneurons synchronously release GABA, which via its excitatory action may serve a neurotrophic function during the refinement of hippocampal circuitry.
Abstract:We have identified a class of tau fragments inducing apoptosis in different cellular contexts, including a human teratocarcinoma-derived cell line (NT2 cells) representing committed human neuronal precursors. We have found a transition point inside the tau molecule beyond which the fragments lose their ability to induce apoptosis. This transition point is located around one of the putative caspase-3 cleavage sites. This is the only site that can be effectively used by caspase-3 in vitro, releasing the C-terminal 19 amino acids of tau. These results establish tau as a substrate for an apoptotic protease that turns tau itself into an effector of apoptosis. Accordingly, tau may be involved in a self-propagating process like what has been predicted for the pathogenesis of different neurodegenerative disorders. Key Words: Microtubule -Tau-Apoptosis-Caspase-3. J. Neurochem. 75, 624 -633 (2000).Proteolysis of cellular proteins is one of the critical mechanisms of apoptosis (Salvesen and Dixit, 1997). Although many protein substrates for apoptosis-activated proteases have been identified, their functional significance is poorly understood. Some of these substrates are cytoskeletal proteins, for example, actin, fodrin, gelsolin, and GAS2 (Brancolini et al
Nerve growth factor (NGF) is involved in pain transduction mechanisms and plays a key role in many persistent pain states, notably those associated with inflammation. On this basis, both the NGF ligand and its receptor TrkA (tyrosine kinase A) represent an eligible target for pain therapy. Although the direct involvement of NGF in pain modulation is well established, the effect of a direct functional block of the TrkA receptor is still unknown. In this study, we have demonstrated that MNAC13, the only anti-TrkA monoclonal antibody for which function neutralizing properties have been clearly shown both in vitro and in vivo, induces analgesia in both inflammatory and neuropathic pain models, with a surprisingly long-lasting effect in the latter. The formalin-evoked pain licking responses are significantly reduced by the MNAC13 antibody in CD1 mice. Remarkably, treatment with the anti-TrkA antibody also produces a significant antiallodynic effect on neuropathic pain: repeated i.p. injections of MNAC13 induce significant functional recovery in mice subjected to sciatic nerve ligation, with effects persisting after administration. Furthermore, a clear synergistic effect is observed when MNAC13 is administered in combination with opioids, at doses that are not efficacious per se. This study represents a direct demonstration that neutralizing antibodies directed against the TrkA receptor may display potent analgesic effects in inflammatory and chronic pain.analgesia ͉ behavior ͉ mice ͉ nerve growth factor
Activation of the Fas death receptor leads to the death of motoneurons in culture. To investigate the role of Fas in programmed cell death and pathological situations, we used several mutant mice deficient for Fas signaling and made a novel transgenic FADD-DN (FAS-associated death domain-dominant-negative) strain. In vitro, motoneurons from all of these mice were found to be resistant to Fas activation and to show a delay in trophic deprivation-induced death. During normal development in vivo, no changes in motoneuron survival were observed. However, the number of surviving motoneurons was twofold higher in animals deficient for Fas signaling after facial nerve transection in neonatal mice. These results reveal a novel role for Fas as a trigger of axotomy-induced death and suggest that the Fas pathway may be activated in pathological degeneration of motoneurons.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.